New hepatitis C therapies approved in Europe

31st July 2017 Uncategorised 0

Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.

More: New hepatitis C therapies approved in Europe
Source: News